Immune cell expression of GABAA receptors and the effects of diazepam on influenza infection

Journal of Neuroimmunology

Volumn 282, Issue , 2015, Pages 97-103

  Sanders, Robert D ^a   Grover, Vimal ^b   Goulding, John ^c   Godlee, Alexandra ^d   Gurney, Stefan ^e   Snelgrove, Robert ^f   Ma, Daqing ^f   Singh, Suveer ^g   Maze, Mervyn ^h   Hussell, Tracy ⁱ  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Manchester Academic Health Science Centre   (United Kingdom)

Author keywords

Benzodiazepine; GABA; Immune; Infection

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; RECEPTOR SUBUNIT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CD14 ANTIGEN; CD45 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL SUPERINFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFLUENZA; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS LOAD; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; NEUTROPHIL; ORTHOMYXOVIRIDAE; PATHOGENICITY; PATHOLOGY; TIME; VIROLOGY;

ANIMALS; ANTIGENS, CD14; ANTIGENS, CD45; BODY WEIGHT; DIAZEPAM; DISEASE MODELS, ANIMAL; FEMALE; GABA MODULATORS; GENE EXPRESSION REGULATION; HUMANS; INFLUENZA, HUMAN; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MONOCYTES; NEUTROPHILS; ORTHOMYXOVIRIDAE; RECEPTORS, GABA-A; TIME FACTORS;

EID: 84928550847     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.04.001     Document Type: Article

References (26)

1. Amarasuriya U.K., Myles P.R., Sanders R.D. Long-term benzodiazepine use and mortality: are we doing the right studies?. Curr. Drug Saf. 2012, 7:367-371.
2. Bautista E., Chotpitayasunondh T., Gao Z., Harper S.A., Shaw M., Uyeki T.M., Zaki S.R., Hayden F.G., Hui D.S., Kettner J.D., Kumar A., Lim M., Shindo N., Penn C., Nicholson K.G. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 2010, 362:1708-1719.
3. Bhat R., Axtell R., Mitra A., Miranda M., Lock C., Tsien R.W., Steinman L. Inhibitory role for GABA in autoimmune inflammation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:2580-2585.
4. Dyson A., Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?. Crit. Care Med. 2009, 37:S30-S37.
5. Fuks J.M., Arrighi R.B., Weidner J.M., Kumar Mendu S., Jin Z., Wallin R.P., Rethi B., Birnir B., Barragan A. GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS Pathog. 2012, 8:e1003051.
6. Galdiero F., Bentivoglio C., Nuzzo I., Ianniello R., Capasso C., Mattera S., Nazzaro C., Galdiero M., Romano C. Effects of benzodiazepines on immunodeficiency and resistance in mice. Life Sci. 1995, 57:2413-2423.
7. Goulding J., Godlee A., Vekaria S., Hilty M., Snelgrove R., Hussell T. Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection. J. Infect. Dis. 2011, 204:1086-1094.
8. Griebel G., Belzung C., Perrault G., Sanger D.J. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology 2000, 148:164-170.
9. Grover V., Pantelidis P., Soni N., Takata M., Shah P.L., Wells A.U., Henderson D.C., Kelleher P., Singh S. A biomarker panel (Bioscore) incorporating monocytic surface and soluble TREM-1 has high discriminative value for ventilator-associated pneumonia: a prospective observational study. PLoS One 2014, 9:e109686.
10. Huemer H.P., Lassnig C., Nowotny N., Irschick E.U., Kitchen M., Pavlic M. Diazepam leads to enhanced severity of orthopoxvirus infection and immune suppression. Vaccine 2010, 28:6152-6158.
11. Laschi A., Descotes J., Tachon P., Evreux J.C. Adverse influence of diazepam upon resistance to Klebsiella pneumoniae infection in mice. Toxicol. Lett. 1983, 16:281-284.
12. Lim W.S., Baudouin S.V., George R.C., Hill A.T., Jamieson C., Le Jeune I., Macfarlane J.T., Read R.C., Roberts H.J., Levy M.L., Wani M., Woodhead M.A. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009, 64(Suppl. 3):iii1-iii55.
13. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., Fritschy J.M., Rulicke T., Bluethmann H., Mohler H., Rudolph U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290:131-134.
14. Lubick K., Radke M., Jutila M. Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C. burnetii: comparison with TLR agonists. J. Leukoc. Biol. 2007, 82:1062-1069.
15. Mckernan R.M., Rosahl T.W., Reynolds D.S., Sur C., Wafford K.A., Atack J.R., Farrar S., Myers J., Cook G., Ferris P., Garrett L., Bristow L., Marshall G., Macaulay A., Brown N., Howell O., Moore K.W., Carling R.W., Street L.J., Castro J.L., Ragan C.I., Dawson G.R., Whiting P.J. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat. Neurosci. 2000, 3:587-592.
16. Mirza N.R., Larsen J.S., Mathiasen C., Jacobsen T.A., Munro G., Erichsen H.K., Nielsen A.N., Troelsen K.B., Nielsen E.O., Ahring P.K. NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitr ile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy. J. Pharmacol. Exp. Ther. 2008, 327:954-968.
17. Obiora E., Hubbard R., Sanders R.D., Myles P.R. The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort. Thorax 2013, 68:163-170.
18. Pandharipande P.P., Sanders R.D., Girard T.D., Mcgrane S., Thompson J.L., Shintani A.K., Herr D.L., Maze M., Ely E.W. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit. Care 2010, 14:R38.
19. Righi D.A., Pinheiro S.R., Guerra J.L., Palermo-Neto J. Effects of diazepam on Mycobacterium bovis-induced infection in hamsters. Braz. J. Med. Biol. Res. 1999, 32:1145-1153.
20. Riker R.R., Shehabi Y., Bokesch P.M., Ceraso D., Wisemandle W., Koura F., Whitten P., Margolis B.D., Byrne D.W., Ely E.W., Rocha M.G. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009, 301:489-499.
21. Rudolph U., Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nat. Rev. Neurosci. 2004, 5:709-720.
22. Sanders R.D., Hussell T., Maze M. Sedation & immunomodulation. Crit. Care Clin. 2009, 25:551-570. (ix).
23. Sanders R.D., Godlee A., Fujimori T., Goulding J., Xin G., Salek-Ardakani S., Snelgrove R.J., Ma D., Maze M., Hussell T. Benzodiazepine augmented gamma-amino-butyric acid signaling increases mortality from pneumonia in mice*. Crit. Care Med. 2013, 41:1627-1636.
24. Uusi-Oukari M., Korpi E.R. Regulation of GABA(A) receptor subunit expression by pharmacological agents. Pharmacol. Rev. 2010, 62:97-135.
25. Wissinger E., Goulding J., Hussell T. Immune homeostasis in the respiratory tract and its impact on heterologous infection. Semin. Immunol. 2009, 21:147-155.
26. Xiang Y.Y., Wang S., Liu M., Hirota J.A., Li J., Ju W., Fan Y., Kelly M.M., Ye B., Orser B., O'Byrne P.M., Inman M.D., Yang X., Lu W.Y. A GABAergic system in airway epithelium is essential for mucus overproduction in asthma. Nat. Med. 2007, 13:862-867.